Main Stories – 第 34 页 – MicroVibeNews

JPHY: New Active Bond ETF With Strong Institutional Support (BATS:JPHY)

This article was…

Amazon: A Correction Under $200 May Be Necessary Before Uptrend Resumes (Technical Analysis)

Amazon: A Correc…

Politics And The Markets 12/25/25

Politics And The…

Immatics Stock: PRAME Leader’s Transition To Commercial Reality (NASDAQ:IMTX)

This article was…

EVG: Attractively Valued And Reliable Monthly Dividend

EVG: Attractivel…

Invesco Limited Term California Municipal Fund Q3 2025 Commentary (OLCAX)

Invesco is an in…

Virtus Newfleet Core Plus Bond Fund Q3 2025 Commentary (SAVAX)

Nikada/E+ via Ge…

Janus Henderson Mid Cap Growth Managed Account Q3 2025 Commentary

Janus Henderson …

Fidelity Real Estate Investment Portfolio Q3 2025 Commentary

Fidelity Real Es…

The AI Revolution: 3 Major Hurdles That Need To Be Overcome In 2026

The AI Revolutio…

Agios Pharmaceuticals, Inc. (AGIO) Discusses FDA Approval of AQVESME for Anemia in Alpha and Beta Thalassemia Transcript

Agios Pharmaceut…

Rivian Needs More Capital: Rating Downgrade (NASDAQ:RIVN)

This article was…

Oramed Pharmaceuticals: Scarred, Well-Capitalized, And Regrouping After Setback

Oramed Pharmaceu…

ZIM Integrated Shipping: Nice Gains, Weaker Outlook

ZIM Integrated S…

Agios Pharma Stock: A Buy After FDA Approves Aqvesme (NASDAQ:AGIO)

This article was…

2026 Market Outlook: Valuation Expectations Are Far More Optimistic Than Analysts (SPY)

This article was…

Fenix Gold Offers Deep Value As Rio2 Production Launches Into A Gold Rush (OTCMKTS:RIOFF)

This article was…

Energy Transfer: Now I'm Getting Even More Bullish (Rating Upgrade)

Energy Transfer:…

EWP: Spanish Stocks To Benefit From Solid GDP Growth In 2026

EWP: Spanish Sto…

Galectin Therapeutics: Runway With Convertible Financing But Dilution Overhang Remains

Galectin Therape…

TEI: Come For The EM Exposure, Stay For The Double-Digit Return

TEI: Come For Th…

Vistra: Undeniable Positives Despite The Downward Drag

Vistra: Undeniab…